Concepedia

Amol N.S. Rakkar

AN

Statistics

Publications

6

Citations

503

H-Index

6

Active since

1997

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Amol N.S. Rakkar is an author at National Cancer Institute specializing in molecular oncology, molecular biology, and life sciences.

Publications per year

1997–1999

6

Publications

6

Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27.

Y. Katayose, M Kim, Amol N.S. Rakkar et al. · PubMed · 1997 · 320 citations

Life Sciences, Cell Biology, Molecular Biology +16

Recombinant Adenovirus Expressing Von Hippel-Lindau-Mediated Cell Cycle Arrest Is Associated with the Induction of Cyclin-Dependent Kinase Inhibitor p27Kip1

Min Kim, Yu Katayose, Qingdi Li et al. · Biochemical and Biophysical Research Communications · 1998 · 56 citations

Life Sciences, Cell Biology, Molecular Biology +12

A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers.

Prem Seth, Dai Katayose, Zhuangwu Li et al. · PubMed · 1998 · 41 citations

Medicine, Molecular Biology, Oncology +16

Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model

Zheng Li, Amol N.S. Rakkar, Y. Katayose et al. · Gene Therapy · 1998 · 39 citations

Medicine, Cancer Biology, Oncology +10

A novel adenoviral vector expressing human Fas/CD95/APO-1 enhances p53-mediated apoptosis

Amol N.S. Rakkar, Yu Katayose, Min Kim et al. · Cell Death and Differentiation · 1999 · 25 citations

Life Sciences, Cancer Biology, Molecular Biology +14

1–5 of 6